HypoxE Test
Pre-clinical- Indications
- Hypoxic ischemic encephalopathy
Company intelligence / Profile preview
InfanDx
Cologne, Nordrhein-Westfalen, Germanyinfandx.com ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Preclinical
01
Overview
The company has completed the validation of metabolic biomarker panels for early detection of HIE in newborns. These validated biomarkers are being developed into the HypoxE blood test to enable rapid and objective diagnosis within six hours after birth. The product aims to support timely neuroprotective interventions that can prevent life-long disabilities caused by HIE. Clinical collaborations have demonstrated strong results, and the company has a clear path toward turning these findings into a commercial IVD product[6].
- Therapeutic areas
- OtherNeurology
- Modalities
- DeviceDiagnostic test (specifically in vitro diagnostic/IVD)
- Industry
- Metabolite Diagnostics
02
Drug pipeline
1 asset03
Partnerships
ELITechGroup (diagnostic development partner)
Beyond the preview
Go deeper on InfanDx.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on InfanDx.